Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GGT1 | P19440 | 1/20 | 0.54 |
| ▸ | ARG1 | P05089 | 1/20 | 0.48 |
| ▸ | ARG2 | P78540 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | BLM | P54132 | 3/20 | 0.38 |
| ▸ | NOS2 | P35228 | 5/20 | 0.38 |
| ▸ | NOS1 | P29475 | 3/20 | 0.38 |
| ▸ | NOS3 | P29474 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.35 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.35 |
| ▸ | EGFR | P00533 | 1/20 | 0.35 |
| ▸ | FYN | P06241 | 1/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL159588 | 1.00 | GGT1 (0.54) | GGT1ARG1ARG2ALDH1A1KMT2A | |
| SCHEMBL164555 | 1.00 | GGT1 (0.54) | GGT1ARG1ARG2ALDH1A1KMT2A | |
| SCHEMBL200536 | 0.83 | ALDH1A1 (0.56) | GGT1ARG1ARG2ALDH1A1KMT2A | |
| SCHEMBL200537 | 0.83 | ALDH1A1 (0.56) | GGT1ARG1ARG2ALDH1A1KMT2A | |
| SCHEMBL473835 | 0.83 | ALDH1A1 (0.56) | GGT1ARG1ARG2ALDH1A1KMT2A | |
| SCHEMBL8687592 | 0.82 | GGT1 (0.65) | GGT1ARG1ARG2ALDH1A1KMT2A | |
| Water SCHEMBL434488 | 0.81 | ALDH1A1 (0.54) | GGT1ARG1ARG2ALDH1A1KMT2A | |
| Water SCHEMBL10780975 | 0.81 | ALDH1A1 (0.54) | GGT1ARG1ARG2ALDH1A1KMT2A | |
| Water SCHEMBL10780977 | 0.81 | ALDH1A1 (0.54) | GGT1ARG1ARG2ALDH1A1KMT2A | |
| SCHEMBL3419878 | 0.80 | ARG1 (0.38) | GGT1ARG1ARG2ALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 313 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12589087-B2 | Enantiomer selective action on neurotransmission | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2026-03-31 | — | — | US | claimed |
| US-20240115539-A1 | ENANTIOMER SELECTIVE ACTION ON NEUROTRANSMISSION | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2024-04-11 | — | — | US | claimed |
| EP-4319735-A1 | ENANTIOMER SELECTIVE ACTION ON NEUROTRANSMISSION | The Board of Trustees of the Leland Stanford Junior University (US) | 2024-02-14 | — | — | EP | claimed |
| CN-117425472-A | Enantioselective action on neurotransmission | 小利兰·斯坦福大学托管委员会 | 2024-01-19 | — | — | CN | claimed |
| WO-2022216543-A1 | ENANTIOMER SELECTIVE ACTION ON NEUROTRANSMISSION | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2022-10-13 | — | — | WO | claimed |
| US-20160318987-A1 | PROTEASE RESISTANT PEPTIDES | MEDIMMUNE LIMITED (GB) | 2016-11-03 | — | — | US | claimed |
| EP-3080153-A2 | PROTEASE RESISTANT PEPTIDES | Medimmune Limited (GB) | 2016-10-19 | — | — | EP | claimed |
| WO-2015086686-A2 | PROTEASE RESISTANT PEPTIDES | MEDIMMUNE LIMITED (GB) | 2015-06-18 | — | — | WO | claimed |
| US-20120264685-A1 | SHORT CHAIN PEPTIDOMIMETICS BASED ORALLY ACTIVE GLP 1 AGONIST AND GLUCAGON RECEPTOR ANTAGONIST | CADILA HEALTHCARE LIMITED (IN) | 2012-10-18 | — | — | US | claimed |
| EP-2491054-A2 | SHORT CHAIN PEPTIDOMIMETICS BASED ORALLY ACTIVE GLP-1 AGONIST AND GLUCAGON RECEPTOR ANTAGONIST | Cadila Healthcare Limited (IN) | 2012-08-29 | — | — | EP | claimed |
| WO-2011048614-A2 | SHORT CHAIN PEPTIDOMIMETICS BASED ORALLY ACTIVE GLP-1 AGONIST AND GLUCAGON RECEPTOR ANTAGONIST | CADILA HEALTHCARE LIMITED (IN) | 2011-04-28 | — | — | WO | claimed |
| WO-2026107423-A1 | ORAL PEPTIDES AND USES THEREOF FOR WEIGHT LOSS, WEIGHT MAINTENANCE, AND MANAGEMENT OF METABOLIC CONDITIONS | METSERA, INC. (US) | 2026-05-21 | — | — | WO | disclosed |
| US-12630600-B2 | GLP-1 and glucagon dual agonist peptides with improved biological stability | MEDIMMUNE LIMITED (GB) | 2026-05-19 | — | — | US | disclosed |
| EP-4736944-A2 | POLYPEPTIDES AND USES THEREOF | MedImmune Limited (GB) | 2026-05-06 | — | — | EP | disclosed |
| US-12589087-B2 | Enantiomer selective action on neurotransmission | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2026-03-31 | — | — | US | disclosed |
| EP-1209234-A1 | STEREOSTRUCTURE OF DECARBAMYLASE AND METHOD OF USING THE SAME | Kaneka Corporation (JP) | 2002-05-29 | — | — | EP | disclosed |
| EP-1015494-A4 | CATALYTIC ANTIBODIES AND A METHOD OF PRODUCING SAME | KOENTGEN FRANK (AU) | 2001-12-12 | — | — | EP | disclosed |
| EP-1015494-A1 | CATALYTIC ANTIBODIES AND A METHOD OF PRODUCING SAME | Amrad Operations Pty.,Ltd. (AU) | 2000-07-05 | — | — | EP | disclosed |
| WO-1999015563-A1 | CATALYTIC ANTIBODIES AND A METHOD OF PRODUCING SAME | AMRAD OPERATIONS PTY. LTD. (AU) | 1999-04-01 | — | — | WO | disclosed |
| WO-1999014243-A1 | IMMUNOINTERACTIVE MOLECULES AND USES THEREFOR | CONE ROBERT EDWARD (US) | 1999-03-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12630600-B2 | GLP-1 and glucagon dual agonist peptides with improved biological stability | GLP1R, GIPR, GCGR | GGT1 1915/4885ARG1 1538/4885ARG2 2286/4885 |
| US-20120264685-A1 | SHORT CHAIN PEPTIDOMIMETICS BASED ORALLY ACTIVE GLP 1 AGONIST AND GLUCAGON RECEPTOR ANTAGONIST | GIPR, GLP1R, DPP4 | GGT1 150/4885ARG1 501/4885ARG2 704/4885 |
| US-12589087-B2 | Enantiomer selective action on neurotransmission | SLC1A2, GLUL, SLC6A13 | GGT1 445/4885ARG1 1491/4885ARG2 800/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.